Drugs already in use could be combined to form a two-pronged attack on advanced prostate cancer, a study suggests.

By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.

A multi-centre study whose leads include London-based researchers has found a new imaging solution that can more effectively ...

An international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one ...

One in every 8 men in the United States will develop prostate cancer, according to prostate cancer statistics released by the American Cancer Society.

A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...

Getty ImagesA major international study has uncovered a new vulnerability in prostate cancer cells that could help improve ...

A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

Phase III trial presented at ASTRO in San Francisco finds five-treatment regimen poised to become new standard of care. SAN FRANCISCO, Sept. 29, 2025 /PRNewswire/ -- Men with intermediate-risk ...